APA

Salas S., Mercier C., Ciccolini J., Pourroy B., Fanciullino R., Tranchand B., Monjanel-Mouterde S., Baciuchka-Palmaro M., Dupuis C., Yang C., Balti M., Lacarelle B., Duffaud F., Durand A. & Favre R. (20061103). Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma. : Therapeutic drug monitoring.

Chicago

Salas Sébastien, Mercier Cédric, Ciccolini Joseph, Pourroy Bertrand, Fanciullino Raphaelle, Tranchand Brigitte, Monjanel-Mouterde Suzanne, Baciuchka-Palmaro Marjorie, Dupuis Charlotte, Yang Chenguang, Balti Medhi, Lacarelle Bruno, Duffaud Florence, Durand Alain and Favre Roger. 20061103. Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma. : Therapeutic drug monitoring.

Harvard

Salas S., Mercier C., Ciccolini J., Pourroy B., Fanciullino R., Tranchand B., Monjanel-Mouterde S., Baciuchka-Palmaro M., Dupuis C., Yang C., Balti M., Lacarelle B., Duffaud F., Durand A. and Favre R. (20061103). Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma. : Therapeutic drug monitoring.

MLA

Salas Sébastien, Mercier Cédric, Ciccolini Joseph, Pourroy Bertrand, Fanciullino Raphaelle, Tranchand Brigitte, Monjanel-Mouterde Suzanne, Baciuchka-Palmaro Marjorie, Dupuis Charlotte, Yang Chenguang, Balti Medhi, Lacarelle Bruno, Duffaud Florence, Durand Alain and Favre Roger. Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma. : Therapeutic drug monitoring. 20061103.